Prior Stephen David
- SEC CIK
- 0002042268
In the past year, 2 open-market sale filings worth $7.36K and no purchases.
Current role at each company
- ANTX AN2 Therapeutics, Inc.Chief Strategy Officeras of Jan 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.36K
- 2 filings
- Net
- −$7.36K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Prior Stephen David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5-6 | 2 days | Prior Stephen DavidChief Strategy Officer | SSale | −6.46K | $1.00 | −$6.49K | −9.9%59.1K after | 2 lots |
| Nov 6, 2025 (view filing) | Nov 4 | 2 days | Prior Stephen DavidChief Strategy Officer | SSale | −765 | $1.14 | −$872.1 | −1.2%65.5K after | |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Prior Stephen DavidChief Strategy Officer | SSale | −2.03K | $1.34 | −$2.72K | −5.7%33.3K after |